European Sleep-Wake Disorder Market Size Analysis, Trends, Industry Outlook and Forecast 2019 - 2025

The European sleep-wake disorder market is estimated to grow at a CAGR of 5.5% during the forecast period. The key driving factor of the market in the region is the increasing sleep-wake disorders due to various behavioral health issues of the population which is expected to promote the demand for sleep-wake disorder treatment solutions, thereby promoting the growth of the market in the near future. According to the NCBI, about three-quarters of depressed patients have insomnia symptoms and hypersomnia. Moreover, there are various organizations that are promoting research on sleep disorders that further contributes to the market. For instance, The European Sleep Research Society is an international non-profit organization that promotes research on sleep and related areas, to improve the care for patients with sleep disorders and to facilitate the distribution of information regarding sleep medicine and sleep research.

Get Sample Copy of European Sleep-Wake Disorder Market at: https://www.omrglobal.com/request-sample/european-sleep-wake-disorder-market

Some of the players operating in the European sleep-wake disorder market include Koninklijke Philips N.V, Medtronic PLC, Sanofi SA, Jazz Pharmaceutical Inc., and others.

Europe consists of numerous key economies consisting of UK, Germany, Italy, Spain, and France among various others. The rest of Europe consists of countries such as Denmark, Belgium, Iceland, the Netherlands, Sweden, Russia and so on. The healthcare expenditure in these countries is also increasing yearly. The increase in the healthcare structure of these countries and the progressive government policies in the healthcare of these countries is focusing on the sleep-wake disorder treatment and research. The Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SSSSC) together include basic science and clinical sleep researchers, chronobiologists and sleep clinicians to promote and stimulate collaboration.

For More Information, get A full report of European Sleep-Wake Disorder Market is available at: https://www.omrglobal.com/industry-reports/european-sleep-wake-disorder-market

The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.
In January 2019, Jazz Pharmaceuticals had received EU Marketing Authorization for SUNOSI (solriamfetol) for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea. The market authorization is anticipated to improve the availability of the drug in Europe.

European Sleep-Wake Disorder Market Segmentation

European Sleep-Wake Disorder Market by Type

o Insomnia
o Hypersomnia
o Circadian Rhythm Disorders
o Others

European Sleep-Wake Disorder Market by Treatment

o Therapies
o Drugs
o Devices

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-sleep-wake-disorder-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.